GlassScriptPhysician profile
George T Talbot
NPI 1669470126
$1,128.32
in general payments reported to CMS, 2019-2025
21 companies · $27.88 in 2025
The $27.88 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $28.95 · 2021: $141 · 2022: $262 · 2023: $314 · 2024: $239 · 2025: $27.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $247.21 | 2019-2024 | Liletta, Lo Loestrin Fe |
| Pfizer INC. | $172.75 | 2021-2024 | |
| Hologic Sales and Service, LLC | $138.16 | 2022-2024 | Acessa Provu System, Aptima |
| Exeltis, USA INC. | $90.05 | 2022-2025 | Slynd |
| Biohaven Pharmaceutical Holding Company LTD. | $76.67 | 2022 | |
| Therapeuticsmd, INC. | $57.16 | 2020-2021 | |
| Astellas Pharma US INC | $52.57 | 2023-2024 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $37.13 | 2022 | |
| Merck Sharp & Dohme LLC | $30.77 | 2019-2024 | Gardasil, Gardasil 9 |
| Organon LLC | $30.53 | 2024 | |
| Abbott Laboratories | $24.27 | 2024 | Proclaim |
| Sanara Medtech INC. | $23.14 | 2021 | |
| Coopersurgical, INC. | $22.77 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $22.07 | 2024 | Exparel |
| Sumitomo Pharma America, INC. | $20.27 | 2023 | Myfembree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.90 | 2024 | |
| Medicem INC. | $15.30 | 2024 | |
| Novo Nordisk INC | $13.85 | 2022 | |
| Mylan Pharmaceuticals INC. | $13.15 | 2022 | |
| Minerva Surgical, INC | $12.92 | 2022 | |
| Mayne Pharma Commercial LLC | $10.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Talbot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.